Multiple active sites and strong US enrollment continue to support Q3 2026 timing for topline data readout Clinical trial sites in Canada and the United Kingdom have received regulatory clearance to enroll All patients who have completed HERO trial to date have successfully...Read more
Giredestrant is the only oral SERD to show superior invasive disease-free survival in the adjuvant setting, marking the first significant endocrine therapy advance in over 20 years Transformational results support the potential of giredestrant to become a new standard-of-care...Read more
TUKYSA, trastuzumab, and pertuzumab reduced the risk of disease progression or death by 36% compared to trastuzumab and pertuzumab alone in Phase 3 HER2CLIMB-05 study The combination demonstrated a manageable safety profile as a first-line maintenance therapy NEW YORK / Dec 10,...Read more
FDA clearance expands da Vinci SP indications to include inguinal hernia repair, cholecystectomy, and appendectomy SUNNYVALE, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery,...Read more
FDA Clearance Granted After Successful Appeal, Overturning Prior Not Substantially Equivalent (NSE) Outcome HeartBeam’s Credit-Card Sized Device Delivers Clinical-Grade Insights Directly to Patients Anytime, Anywhere Pivotal Milestone Unlocks Multiple Key Initiatives in Company’s Growth...Read more
Phase 1 dose escalation trial of monotherapy IDE574 expected to begin in 1Q 2026 Targeting to present preclinical data detailing pharmacologic profile and evidence of anti-tumor activity in solid tumor models at a medical conference in 1H 2026 SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025...Read more
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE| Company | Change | Last Trade |
|---|---|---|
| Mettler-Toledo | 34.43 2.51 | $1,405.85 |
| Regeneron Pharmaceuticals | 33.63 4.86 | $726.21 |
| McKesson | 18.09 2.28 | $813.10 |
| Medpace | 16.67 3.06 | $560.75 |
| Penumbra | 15.93 5.55 | $303.07 |
| Eli Lilly | 11.42 1.16 | $993.64 |
| Elevance Health | 11.23 3.40 | $341.04 |
| Thermo Fisher Scientific | 10.74 1.91 | $573.81 |
| Waters | 9.66 2.50 | $395.82 |
| Becton Dickinson | 9.58 5.07 | $198.40 |
| Charles River Laboratories | 8.86 4.76 | $194.85 |
| United Therapeutics | 8.50 1.78 | $484.86 |
| Nutex Health | 8.05 4.78 | $176.47 |
| Vertex Pharmaceuticals | 7.63 1.75 | $444.64 |
| Danaher | 7.19 3.22 | $230.42 |
| Bright Minds Biosciences | 6.99 9.03 | $84.39 |
| Bio-Rad Laboratories | 6.95 2.26 | $315.00 |
| Movano Health | 6.40 205.79 | $9.51 |
| Company | Volume | Last Trade |
|---|---|---|
| WORK Medical Technology | 941,826,222 | $0.17 |
| HeartBeam | 737,408,425 | $1.49 |
| iBio | 143,189,858 | $2.83 |
| Incannex Healthcare | 81,012,018 | $0.42 |
| Scienture | 60,591,844 | $0.63 |
| Wave Life Sciences | 48,226,987 | $20.23 |
| Pfizer | 42,299,788 | $25.77 |
| Applied Therapeutics | 40,918,780 | $0.22 |
| Reviva Pharmaceuticals | 26,975,859 | $0.73 |
| Absci | 24,110,424 | $3.98 |
| Warby Parker | 23,022,730 | $29.57 |
| Dyne Therapeutics | 22,327,509 | $19.69 |
| Senti Biosciences | 20,899,709 | $1.48 |
| Geron | 20,294,801 | $1.28 |
| Recursion | 19,872,059 | $4.77 |
| Aptevo Therapeutics | 19,109,959 | $1.19 |
| Palisade Bio | 18,485,265 | $2.10 |
| Biodexa Pharmaceuticals | 16,503,566 | $6.68 |
| Enveric Biosciences | 16,349,206 | $10.26 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets...
CLICK TO LEARN MORE
Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
